(Total Views: 490)
Posted On: 03/08/2019 2:55:02 PM
Post# of 30066
Re: jamesfranklin #27628
I'm not sure what you're asking.
It sounds like, you're wondering if TODOS will strategically authorize more shares to lessen AMBS' ownership percentage once uplisted?
1. How could they "water down" only AMBS' shares?
2. If AMBS owns 50% of Todos why would they agree and vote for that?
They could just not purchase the the rest of Breakthrough DX.
"Under the terms of the JV Agreement, Todos Medical, has an exclusive option to acquire the remaining 80.01% of Breakthrough Diagnostics in exchange for an additional 30.01% of Todos Medical’s shares."
The Breast Cancer DX is pretty amazing and I like the fact they are looking to become The Standard add on test and not shooting for a full replacement. Trying to overthrow a gold standard already set in place is a near impossible task, so better to become the Gold Standard add-on that improves outcomes.
Then expand on it's abilities.
Aloha
It sounds like, you're wondering if TODOS will strategically authorize more shares to lessen AMBS' ownership percentage once uplisted?
1. How could they "water down" only AMBS' shares?
2. If AMBS owns 50% of Todos why would they agree and vote for that?
They could just not purchase the the rest of Breakthrough DX.
"Under the terms of the JV Agreement, Todos Medical, has an exclusive option to acquire the remaining 80.01% of Breakthrough Diagnostics in exchange for an additional 30.01% of Todos Medical’s shares."
The Breast Cancer DX is pretty amazing and I like the fact they are looking to become The Standard add on test and not shooting for a full replacement. Trying to overthrow a gold standard already set in place is a near impossible task, so better to become the Gold Standard add-on that improves outcomes.
Then expand on it's abilities.
Aloha
(2)
(0)
